Acurx Pharmaceuticals, Inc.
ACXP
$0.335
$0.0051.52%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 3.71M | 5.76M | 6.36M | 8.92M | 7.47M |
| Total Receivables | 51.10K | 97.40K | 51.10K | -- | 129.20K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 100.10K | 122.80K | 168.40K | 187.90K | 105.80K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 3.86M | 5.98M | 6.58M | 9.11M | 7.71M |
|
|
|||||
| Total Current Assets | 3.86M | 5.98M | 6.58M | 9.11M | 7.71M |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 3.86M | 5.98M | 6.58M | 9.11M | 7.71M |
|
|
|||||
| Total Accounts Payable | 4.80K | 19.10K | 10.10K | 9.20K | 3.80K |
| Total Accrued Expenses | 3.24M | 3.30M | 3.14M | 3.10M | 3.04M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 3.24M | 3.32M | 3.15M | 3.11M | 3.04M |
|
|
|||||
| Total Current Liabilities | 3.24M | 3.32M | 3.15M | 3.11M | 3.04M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 3.24M | 3.32M | 3.15M | 3.11M | 3.04M |
|
|
|||||
| Common Stock & APIC | 67.94M | 67.20M | 65.15M | 63.60M | 57.89M |
| Retained Earnings | -67.32M | -64.54M | -61.72M | -57.60M | -53.22M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 615.10K | 2.66M | 3.43M | 6.00M | 4.67M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 615.10K | 2.66M | 3.43M | 6.00M | 4.67M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 615.10K | 2.66M | 3.43M | 6.00M | 4.67M |
|
|
|||||
